The Morning Call
A significant breakthrough may have been recorded in the search for effective treatment and cure for the deadly HIV virus. Scientists say a new HIV vaccine candidate has been trialled in humans and monkeys, with promising results.
Nearly 400 healthy, uninfected adults are reported to have mounted an immune response against the vaccine and tolerated it well, according to the latest study published in The Lancet.
It’s a quest that’s been nearly 40 years in the making. Lead researcher Dan Barouch from Harvard Medical School said the study was an “important milestone” in HIV research, but that the results should be interpreted with caution.
So are we one step closer to finding effective treatment for HIV?
01:30
Global funding cuts devastating HIV prevention programmes says UNAIDS
Go to video
UNICEF secures agreement to cut malaria vaccine costs
Go to video
Eswatini is the first African country to get twice-yearly HIV prevention shot
Go to video
Europe is not doing enough to detect HIV, hepatitis, health authorities warn
00:54
A third of Japan-donated Mpox vaccines wasted in DRC due to storage challenges
01:31
South Africa starts clinical trials on first locally developed oral cholera vaccine